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Differentiation capacity and maintenance of
differentiated phenotypes of human mesenchymal
stromal cells cultured on two distinct types of 3D
polymeric scaffolds†
A. M. Leferink,ab D. Santos,a M. Karperien,c R. K. Truckenmüller,ab
C. A. van Blitterswijkab and L. Moroni‡*ab
Many studies have shown the influence of soluble factors and material properties on the differentiation
capacity of mesenchymal stromal cells (MSCs) cultured as monolayers. These types of two-dimensional
(2D) studies can be used as simplified models to understand cell processes related to stem cell sensing and
mechano-transduction in a three-dimensional (3D) context. For several other mechanisms such as cell–cell
signaling, cell proliferation and cell morphology, it is well-known that cells behave differently on a planar
surface compared to cells in 3D environments. In classical tissue engineering approaches, a combination
of cells, 3D scaffolds and soluble factors are considered as the key ingredients for the generation of
mechanically stable 3D tissue constructs. However, when MSCs are used for tissue engineering strategies,
little is known about the maintenance of their differentiation potential in 3D scaffolds after the removal of
differentiation soluble factors. In this study, the differentiation potential of human MSCs (hMSCs) into the
chondrogenic and osteogenic lineages on two distinct 3D scaffolds, additive manufactured electrospun
scaffolds, was assessed and compared to conventional 2D culture. Human MSCs cultured in the presence
of soluble factors in 3D showed to differentiate to the same extent as hMSCs cultured as 2D monolayers or
as scaffold-free pellets, indicating that the two scaffolds do not play a consistent role in the differentiation
process. In the case of phenotypic changes, the achieved differentiated phenotype was not maintained
after the removal of soluble factors, suggesting that the plasticity of hMSCs is retained in 3D cell culture
systems. This finding can have implications for future tissue engineering approaches in which the validation
of hMSC differentiation on 3D scaffolds will not be sufficient to ensure the maintenance of the functionality of
the cells in the absence of appropriate differentiation signals.
Insight, innovation, integration
The scientific research presented in our manuscript shows the response of human bone marrow stromal cells (hMSCs) on differentiation-inducing-soluble
factors in two distinct 3D polymeric scaffolds. Our work contributes to further understanding of the maintenance of differentiated hMSC phenotype. Cell
populations which appeared to be successfully differentiated towards the chondrogenic or osteogenic lineage did not always maintain this differentiated state
upon soluble factor removal. From these results, we conclude that in vitro differentiation will not necessarily result in sufficient functionality of these tissue
constructs, for example, upon implantation in vivo. This also indicates that the conventional assessment of the differentiated phenotype will not be sufficient to
be able to predict the cells’ functionality in clinical applications.
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1. Introduction
Multipotent cell types are promising candidates for classical tissue
engineering and regenerative medicine approaches in which a
synthetic or biological material is combined with autologous cells
to construct a mechanically stable implant to replace damaged or
lost tissue. The use of multipotent cell types is opted since many
other differentiated cell types have limited availability and several
cell types have shown to lose their phenotype upon expansion by
a process known as de-differentiation.1–4 This can result in a
decreased functionality of the cells, which lowers their potential
to secrete specific tissue components within the construct. A cell
type that can circumvent this problem is human adult stem cells
from bone marrow stroma, referred to as human mesenchymal
stem or stromal cells (hMSCs). MSCs were initially defined as a
heterogeneous population of fibroblast-like cells, from which a
subset of the population has great potential to proliferate and
differentiate.5–8 More recent definitions consist of minimal criteria
to identify multi-potent hMSCs, which include specific surface
antigen expression and multipotent differentiation potential
into osteoblasts, adipocytes and chondrocytes.9–11 Recent studies
showed that by culturing hMSCs on biomaterials with controlled
properties, or by adding certain soluble factors, depending on the
donor and isolation method, differentiation towards chondro-
genic,12–14 osteogenic,15–17 neurogenic,18 endothelial19 and
myogenic20 lineages can be achieved.
A large number of studies have shown the influence of soluble
factors and material properties on the differentiation capacity of
MSCs in two-dimensional (2D) culture systems.21 For example,
Engler et al. reported on the influence of gel stiffness on the fate of
stem cells.22,23 In other studies, nano- and micro-topographies
were introduced to investigate the influence of physical properties
like roughness of the material on cell differentiation.24–27 These
types of studies can be used as simplified models to understand
cell processes related to stem cell sensing and mechano-
transduction in three-dimensional (3D) environments. However,
cells in a tissue, organ or organism are exposed to complex
biological environments. In contrast to classic culture systems,
these environments are not flat, but 3D. Consequently, 2D tissue
culture models used to translate a new therapy to the clinics are far
from accurate. For several other mechanisms like cell–cell signal-
ling, cell proliferation and cell morphology, it is well-known that
cells behave differently on a 2D flat surface compared to cells in 3D
systems.28 Although the lineage of MSCs, plasticity and therapeutic
potential have been widely studied in 2D, little is known about
these combined properties in 3D.29 In particular, plasticity is the
ability of mature cells to switch or differentiate among phenotypes
that are different from the tissue of origin or different from their
phenotype after considerable differentiation.30,31 Rottmar et al.
recently showed that hMSCs retain their plasticity after 18 days of
2D in vitro culture under osteogenic culture conditions.32 To
our knowledge, phenotypic plasticity of hMSCs after osteogenic
or chondrogenic differentiation has not yet been assessed in 3D
scaffolds for tissue engineering approaches.
In this study, the differentiation potential of hMSCs into
the chondrogenic and osteogenic lineages on two distinct 3D
scaffolds, both of which have been opted as potential scaffolds
for bone and cartilage tissue engineering applications,33,34 was
assessed and compared to the differentiation capacity in 2D
monolayer cultures and in chondrogenic pellet-culture. The
maintenance of the induced differentiated phenotype was
assessed after the removal of soluble factors to investigate the
role of the 3D culture system in phenotypic alterations of cells.
For both scaffold architectures, a previously optimized cell
number for the estimated available surface area was applied.
However, the cell seeding density was kept constant to allow for
comparable cell adherence conditions.35 After 7 days of cell
adherence and culture in proliferation medium, differentiation
inducing media were added to the cultures. As commonly used
to steer hMSC differentiation, 10 nM dexamethasone (dex) was
supplemented to the medium for osteogenic differentiation,
while 100 nM of dex and 10 ng mL1 of TGF-b3 were introduced
for chondrogenic differentiation.
After 14 days of differentiation, the soluble factors were
removed (de-differentiation phase) and the cellular phenotype
was assessed after 3 or 14 days of potential de-differentiation.
We hypothesize that after the removal of differentiation inducing
soluble factors, the stability of hMSC phenotype may be altered in
3D similarly to what was reported for hMSC phenotype in 2D
culture.29,36 Ultimately, this may have an influence on developing
stem cell based regenerative medicine strategies in which 3D
constructs loaded with hMSCs are implanted in vivo subsequent
to culture in vitro. In these approaches, the traditional assessment
of the differentiation potential hMSCs in 3D constructs will not be
sufficient to predict the functionality of hMSCs upon implantation
without assessing the stability of the differentiated phenotype
of hMSCs.
2. Materials and methods
2.1. Cell culture and culture media
Basal medium (BM) consisted of a-minimal essential medium
(Life Technologies) complemented with 10% heat-inactivated
fetal bovine serum (FBS; Lonza), 0.2 mM ascorbic acid (Asap;
Life Technologies), 2 mM L-glutamine (Life Technologies),
100 units per mL penicillin (Life Technologies), and 10 mg mL1
streptomycin (Life Technologies). Proliferation medium (PM)
consisted of BM supplemented with a 1 ng mL1 basic fibroblast
growth factor (FGF; Instruchemie). Osteogenic medium (OM)
consisted of BM supplemented with 10 nM dex. Bone-gla-protein
(BGP) was omitted, since it is known to aid in the differentiation
of osteoblasts into mineral forming osteocytes and not necessarily
in the early phase of osteoblastic differentiation. In this study, we
only looked at early indicators of differentiation and not at miner-
alization. Chondrogenic medium (CM) consists of Dulbecco’s
modified Eagle medium (D-MEM, Life Technologies) comple-
mented with 0.2 mM ascorbic acid, 100 units per mL penicillin
(Life Technologies), 10 mg mL1 streptomycin (Life Techno-
logies), 50 mg mL1 ITS-premix, 100 mg mL1 sodium pyruvate,
10 ng mL1 TGFb-3 and 100 nM dex. For the studies presented
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For all experiments, hMSCs selected based on their potential
to propagate and differentiate (referred to as donor 1) were
utilized unless stated differently.
These pre-selected hMSCs (male, age 22) were retrieved from
the Institute of Regenerative Medicine (Temple, Texas).8,37
Briefly, a bone marrow aspirate was drawn and mononuclear
cells were separated by density centrifugation. The cells were
plated to obtain adherent hMSCs, which were harvested when
cells reach 60–80% confluence. These were considered passage
zero (P0) cells. These P0 cells were expanded, harvested and
frozen at passage 1 (P1) for distribution.
Donor 2, 3, and 4 hMSCs (female, age 55; male, age 75; and
female, age 76; respectively) were obtained by bone marrow
aspiration from patients who had given written informed con-
sent. These hMSCs were isolated and proliferated as previously
described.38 In short, aspirates from the donors were resus-
pended using a 20-gauge needle, plated at a density of 5  105
cells per cm2 and cultured in PM. Cells were grown at 37 1C in a
humidified atmosphere with 5% CO2. Medium was refreshed
twice per week and cells were used for further subculturing or
cryopreservation on reaching near confluence.
2.2. Fabrication of 3D scaffolds from PEOT/PBT by fused
deposition modelling (FDM)
Scaffolds were fabricated from 300PEOT55PBT45 (300/55/45)
(PolyVation, The Netherlands), a block copolymer composed of
poly(ethylene oxide terephthalate) (PEOT) and poly(butylene
terephthalate) (PBT) with a weight ratio of 55 to 45 for the two
components, respectively, and a molecular weight of the starting
poly(ethylene glycol) (PEG) segments of 300 Da used in the
co-polymerization process. Fused deposition modeling was used
to fabricate 3D grids using a bioscaffolder (SysENG, Germany), as
described before.33 Grids had a height of 3 mm, a fiber-to-fiber
distance of 800 mm (XY spacing), a fiber diameter of approximately
200 mm, and a layer thickness of 150 mm (Z spacing). Cylindrical
scaffolds with a diameter of 4 mm and a height of 3 mm were
punched from the plotted grids. The morphology of the fabricated
scaffold is shown (in the z-direction) in Fig. 1A and C.
2.3. Fabrication of 3D scaffolds from PEOT/PBT by
electrospinning (ES)
For ES scaffolds, a 28% (w/v) solution of 300/55/45 was prepared
in a mixture of chloroform (CHCl3)–1,1,1,3,3,3-hexafluoro-2-
propanol (HFIP) with a ratio of 78–22% v/v. The solution was
left for stirring at room temperature overnight. Subsequently,
the solution was loaded into a syringe and pumped at a controlled
flow rate using a syringe pump (KDS 100, KD Scientific). PTFE
tubing was used to connect the syringe and a needle to which a
high voltage was applied (Gamma High Voltage Research Inc., FL,
USA). A stainless steel collector, covered by an aluminium foil, was
used to collect the spun scaffold. Scaffolds were produced using
a voltage of 12 kV applied to a 1.2 mm needle and placed at a
distance of 25 cm from the collector. The flow rate was set at
15 mL h1, temperature to 25 1C, and humidity to 30%. The
morphology of the fabricated scaffold is shown in Fig. 1B and D.
2.4. Cell culture in 2D on tissue culture polystyrene (TCPS)
The differentiation potential of the hMSCs without the presence
of a 3D scaffold system was determined by culture of hMSCs as a
monolayer in BM and OM and as pellet-culture in CM.7 The cells
from all donors were seeded with a density of 5000 cells per cm2
on TCPS 6-well plates (NUNC) and cultured for 3, 7 or 14 days in
BM as a negative control on differentiation and in OM to induce
osteogenic differentiation. For the chondrogenic differentiation in
pellet-culture, 200 000 hMSCs per well were added in a U-bottom
96-well plate for suspension culture (NUNC), centrifuged for 3 min
at 800g and cultured for 3, 7 or 14 days in CM.
Fig. 1 Two distinct types of scaffolds were used to assess hMSC differentiation capacity in vitro in 3D. (A and C) Cylindrical FDM-scaffolds were
fabricated of 300/55/45 with a diameter of 4 mm and a height of 3 mm. (B and D) ESP scaffolds were fabricated of the same polymer as FDM-scaffolds
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2.5. Cell culture on FDM-scaffolds
Sterilization of the scaffolds was performed in 70% ethanol
twice for 30 minutes, subsequently washed in PBS first for
5 minutes and additionally twice for another 30 minutes each
time and finally incubated in BM overnight prior to cell culture.
Scaffolds were dried by medium aspiration and placed in a non-
treated 48-well plate (NUNC). Passage 3 hMSCs were harvested
from monolayer expansion, and seeded on the scaffolds with a
density of 125 000 cells in 50 mL of PM, which has shown to be
in the optimal range of cell densities for a high cell seeding
efficiency.35 After 1.5 hour incubation to let the cells adhere, the
medium was filled up to 1 mL and culture was continued for
7 days to allow the cells to spread and proliferate on the
scaffold. After 7 days of culture in PM, the media were changed
to BM, CM or OM. After 14 days of culture in CM or OM, culture
in CM or OM was continued up to 28 days or the soluble factors
were removed by replacing CM and OM with BM (referred to as
CB and OB respectively).
2.6. Cell culture on ES-scaffolds
The scaffolds were washed with sterile PBS to remove any
remaining traces of ethanol and then placed into a non-treated
24-well plate (NUNC). Non-treated plates were used to minimize
cell attachment to the bottom of the plates. The constructs were
then incubated at 37 1C in a humid atmosphere with 5% CO2
overnight in BM to pre-wet them. To prevent the scaffold discs
from floating, rubber O-rings (Eriks BV, The Netherlands) were
used to hold the discs in place. After removing the medium used
for incubation, 75 000 cells were seeded in 30 mL of PM onto each
electrospun scaffold. The cell number was chosen as such to
maintain the cell seeding concentration similar to on the FDM
scaffolds, yet preventing over-confluence of the top-layer of the
ESP-scaffold. After 1.5 h of incubation to let the cells adhere, the
medium was filled up to 1 mL and culture was continued for
7 days to allow the cells to spread and proliferate on the scaffold.
After 7 days of culture in PM, the media were replaced with BM,
CM and OM to induce differentiation and the culture was
continued as depicted in Fig. 1. After 14 days of culture in CM
or OM, culture in CM or OM was prolonged up to 28 days or the
soluble factors were removed by replacing CM and OM with BM
(referred to as CB and OB respectively).
2.7. Gene expression analysis of hMSCs
For gene expression analysis, samples were taken from culture
after the medium was carefully aspirated. All samples were
transferred to 2 mL Eppendorf tubes and 500 mL of TRIzol
(Invitrogen) was added prior to preservation at 80 1C. RNA
isolation was performed by using a Bioke RNA II nucleospin
RNA isolation kit (Macherey-Nagel). The samples were dis-
rupted mechanically by crushing using RNA isolation pestles
(Kimble Kontes). Samples for basal gene expression analysis
were seeded in T25 tissue culture flasks (NUNC) in BM at a cell
density of 5000 cells per cm2. After 1 day of culture, the medium
was aspirated and 500 mL of TRIzol was added after which the
cell/TRizol suspension was transferred to an Eppendorf tube.
Subsequently, 200 mL of CHCl3 was added to all samples, both
from 2D as well as from 3D culture, and mixed by vigorously
shaking the tubes. The TRizol/CHCl3 mixture was centrifuged
at 12 000g for 15 minutes at 4 1C. The aqueous phase was
transferred to a new Eppendorf tube and mixed 1 : 1 with 70%
ethanol. The mixture was transferred to filter columns from the
kit and RNA isolation was continued following the manufac-
turer’s protocol. RNA concentrations and purity were deter-
mined by using an ND1000 spectrophotometer (Nanodrop
Technologies, USA). CDNA was synthesized from 240, 320 and
600 ng of RNA for the samples from FDM-scaffolds, ES-scaffolds
and 2D respectively, using iScriptt (BIO-RAD) according to the
manufacturer’s protocol. Quantitative polymerase chain reaction
(qPCR) was performed on the obtained cDNA by using the iQ
SYBR Green Supermix (Bio-Rad) and the primers as listed in the
ESI,† in Table S1.
PCR reactions were carried out on the MyiQ2 Two-Color
Real-Time PCR Detection System (Bio-Rad) under the following
conditions: cDNA was denatured for 10 min at 95 1C, followed
by 40 cycles, consisting of 15 s at 95 1C, 30 s at 60 1C, and 30 s at
72 1C. For each reaction, a melting curve was generated to test
primer dimer formation and nonspecific priming. The cycle
threshold (CT) values were determined using the Bio-Rad iQ5
optical system software, in which a threshold value was set for
the fluorescence signal at the lower log-linear part above the
baseline. CT values were normalized to the B2M housekeeping
gene and DCT ((average of CTcontrol)  CTvalue). Results are
expressed as relative mRNA expression calculated as fold induc-
tion (FI) equal to 2DCT and subsequently normalized to the basal
gene expression levels determined after one day in 2D culture
(n = 6). All values representing down-regulation (fold induction
(FI) o 1) are represented as 1/FI and error bars represent
standard deviations which are determined accordingly.
2.8. DNA assay
After the samples were lysed for alkaline phosphatase (ALP) activity,
the lysate was mixed in a 1 : 1 volume ratio with 1 mg mL1
proteinase K (Sigma-Aldrich), 18.5 mg mL1 iodoacetamine (Sigma
Aldrich) and 1 mg mL1 pepstatin A (Sigma Aldrich) in Tris/EDTA
buffer (pH 7.6) and incubated for 16 hours at 56 1C. Quantification
of total DNA was done using the CyQuantt DNA assay (Molecular
Probes) and a spectrophotometer (excitation 480 nm, emission
520 nm) (Victor 3, Perkin Elmer).
2.9. ALP activity assay
After culture, all scaffolds were washed gently in PBS, dried by
aspirating the PBS, cut in pieces and stored at 80 1C for at
least 24 hours. After thawing, the constructs were incubated in
a cell lysis buffer with a pH of 7.8 composed of 0.1 M KH2PO4,
0.1 M K2HPO4 and 0.1% Triton X-100, (all Acros Chemicals) for
1 hour at room temperature. Subsequently, the relative ALP activity
was determined by chemo-luminescence using CDP-stars (Roche)
according to the manufacturer’s protocol. The ALP activity was
normalized to DNA quantity per sample and the averages per
condition were presented as a relative value compared to the
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2.10. GAG assay
The amount of GAG was determined spectrophotometrically after-
reaction with dimethylmethylene blue dye (DMMB, Sigma-Aldrich)
in a solution consisting of 16 mg L1 DMMB, 10 mM hydrochloric
acid, 3.04 g L1 of glycine and 2.37 g L1 of NaCl (pH 3). A micro
plate reader (Multiskan GO, Thermo Fisher) was used to determine
the absorbance at 525 nm. The amount of GAG was calculated
using a standard of chondroitin sulfate (Sigma-Aldrich). The GAG
production was normalized to DNA quantity per sample.
2.11. Scanning electron microscopy (SEM) analysis
Cell morphology, attachment and distribution were characterized
by SEM analysis using a Philips XL 30 ESEM-FEG. Samples were
fixed for 30 minutes in 10% formalin. Subsequently, the samples
were dehydrated in sequential ethanol series and critical point
dried from liquid carbon dioxide using a Balzers CPD 030 Critical
Point Dryer. The constructs were gold sputter-coated (Cressing-
ton) prior to SEM analysis. SEM images were obtained under
high vacuum with an acceleration voltage of 30 kV and a working
distance of 10 mm.
2.12. Statistical analysis
Results are presented as mean  standard deviation, and com-
pared using one-way ANOVA with Dunnett’s post-test. Statistical
significance between the control group and the experimental
groups is indicated with (#) which represents a p-value o 0.05,
(@) which represents a p-value o 0.01, and (*) which represents a
p-value o 0.001.
2.13. Ethics statement
Donor 1 hMSCs were isolated and provided by the Texas A&M
Health Science Center College of Medicine Institute for Regen-
erative Medicine at Scott & White in compliance with relevant
laws and institutional ethics guidelines.
Donor 2, 3, and 4 hMSCs were isolated from human bone
marrow from donors after written informed consent. This study
was carried out in strict accordance with the recommendations
of Medisch Ethische Toetsings Commissie Twente (Medical Ethical
Research Committee Twente) and was approved by this Committee
in compliance with relevant laws on the application of biological
materials from a human source for research purposes.
3. Results
To first gain insight into the differentiation potential of
hMSCs when cultured on the selected 3D polymeric scaffolds,
before looking into phenotype maintenance, differentiation
was induced by soluble factors. All results presented in the
main figures were retrieved from donor 1, referred to as pre-
selected hMSCs, unless stated otherwise. Donor 1 hMSCs have
been selected after being tested positive for the capacity to form
colonies (CFUs) and the differentiation potential of these cells
in the colonies towards the osteogenic and adipogenic lineages
according to protocols reported previously.8 To be able to
compare these results with the results from a more clinically
relevant heterogeneous population of non-tested hMSCs (donor
2, 3 and 4), every experiment was carried out for at least one
of those donors for which the results can be found in the ESI.†
An overview of the whole data-set can be found in Table S2
in the ESI.†
3.1. Differentiation potential of hMSCs in 3D scaffolds by
qPCR
The differentiation potential of hMSCs was assessed by mRNA
expression analysis and normalized to the expression levels
after 1 day of monolayer culture (2D) in the basal medium.
RT-QPCR analysis shows the relative mRNA expression of Alkaline
Phosphatase (ALP) as an early marker for osteogenesis and Sox9
as an early marker for chondrogenesis (Fig. 2). A significant
up-regulation of ALP over time was found for hMSCs cultured
as a monolayer in OM on TCPS. In CM in 2D culture an initial
down-regulation of ALP was found; after 7 and 14 days of
culture the ALP expression was too low to be detected and
was therefore not displayed. Comparing these results to the
gene expression levels in 3D in the two scaffolding systems, it
could be seen that also in 3D in both scaffold types only OM
consistently induced a significant up-regulation of ALP. CM
seemed to slightly down-regulate the expression of ALP on
ES-scaffolds similarly as in 2D. In BM, the ALP expression did
not show any significant changes over time in 2D or in any of the
scaffold systems. When looking at the relative expression levels,
it could be seen that in 2D a 10-fold increase of ALP expression
was found after 14 days of culture, which is in the same order
as the fold increase in FDM and ES-scaffolds after 14 days. In
ES-scaffolds this up regulation of ALP expression is increasing
even more than a 40-fold increase after 28 days of culture.
Sox9 expression was significantly down-regulated in 2D
culture under nearly all conditions but most profoundly in
OM. In 3D, there was a significant up-regulation observed for
Sox9 expression after 7 and 28 days of culture in CM on FDM-
scaffolds. On ES-scaffolds an initial significant increase of Sox9
expression was found after 7 days of culture in CM while the
gene seemed to be down-regulated at day 14 and 28.
Collagen type-1 (collagen-1) and collagen type-2 (collagen-2)
were assessed as markers for ECM production (Fig. 3). In 2D on
TCPS, the expression of both collagen-1 and collagen-2 was
significantly down-regulated in CM after 3 and 7 days. However,
for collagen-2 this change in mRNA expression levels was not
statistically significant. In 3D, the expression of both genes
followed similar trends over time per scaffolding system. A
down-regulation of both collagen-1 and collagen-2 was found in
BM after 3 days of culture on FDM scaffolds in comparison to
hMSCs in BM after 1 day of 2D culture. The expression of
collagen-1 and collagen-2 fluctuated over-time and remained
down-regulated after 28 days of culture in BM in both scaffold
types. In CM, both genes showed up-regulation after 3 and 7 days
of culture, thus suggesting an influence at early culture times of
chondrogenic soluble factors on the expression of collagen type-1
and collagen type-2. However, similar to that in BM, in CM
also the gene expression levels fluctuated for later time-points.
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in the fluctuating gene expression levels, except for ES-scaffolds
after 21 days of culture. This implied that the addition of osteo-
genic soluble factors did not directly correlate with the expression
of collagen type-1 and collagen type-2 genes on these 3D
scaffolds.
Another set of genes related to hMSC differentiation was
assessed for donor 1 hMSCs cultured in 2D as a monolayer and
in 3D on FDM-scaffolds and reported in the ESI,† Fig. S1.
Aggrecan (ACAN), which is involved in chondrogenesis, showed
a significant up-regulation in OM after 3 days of culture on TCPS.
On FDM-scaffolds ACAN showed a significant up-regulation after
7 and 28 days of culture on FDM-scaffolds in CM. BMP2 was
assessed as a gene involved in osteogenesis. Culture in BM in 2D
resulted in a significant 5- to 6-fold down-regulation of BMP2
expression after 3, 7 and 14 days. In contrast to the results in 2D,
a significant up-regulation of BMP2 was found in BM after 7, 14
and 21 days of culture on FDM-scaffolds, whereas in CM and
OM, no significant change in BMP2 expression was found. The
activated leukocyte cell adhesion molecule (ALCAM), related to
the cell surface marker CD166, is often described as an indicator
of the clonogenic potential of hMSCs.39 It can be seen that
ALCAM was significantly down-regulated a two-fold in all time-
points under nearly all conditions on FDM-scaffolds. Similar
results were found in BM in 2D culture in which a significant
down-regulation of 1.6, 2.3 and 3.5 fold was observed after 3, 7
and 14 days, respectively.
To compare the results of the pre-selected hMSCs in 2D to
the results of the more heterogeneous population of hMSCs
from donor 2 (ESI,† Fig. S2) and donor 4 (ESI,† Fig. S3), these
cells were also cultured on 2D scaffolds for 1 and/or 3, 7 and
14 days. In 2D culture, it could be seen that similar to the
results for pre-selected hMSCs the ALP expression was down-
regulated in CM for both donors. In OM, Sox9 expression was
also down-regulated, while the expression of collagen-1 and
collagen-2 showed similar trends per donor and seemed to
fluctuate between a 2-fold up- and down-regulation without a
consistent change in both donors. In contrast to the results on
ACAN expression for pre-selected hMSCs (donor 1) in 2D,
hMSCs from donor 4 showed an increase in ACAN expression
after 14 days of culture in CM.
To compare the expression levels of pre-selected hMSCs on
3D scaffolds to the more heterogeneous population of hMSCs
from donor 2 and donor 3, cells were cultured for 3, 7, 14, 21
and 28 days on FDM- (ESI,† Fig. S4) and on ES-scaffolds (ESI,†
Fig. S5) for these two donors, respectively. Donor 2 generally
showed no profound gene expression level changes between the
differentiation inducing culture media (OM and CM) and BM
for all genes. Also donor 3 on ES-scaffolds showed no apparent
differences in gene expression levels for ALP, ACAN and ALCAM
between the different culture media. Compared to 2D culture at day
1, all conditions of donor 3 showed a significant down-regulation of
ALP at all time-points and a significant up-regulation of ALCAM.
Fig. 2 RT-QPCR analysis was carried out to determine the relative mRNA expression of ALP and Sox9 for pre-selected hMSCs cultured in 2D as
monolayers (BM and OM) or pellets (CM) on TCPS and in 3D in two different scaffold systems. The mRNA expression levels were normalized and
compared statistically to hMSCs cultured for 1 day as a monolayer in BM on TCPS. ALP gene expression was significantly up-regulated over time for
hMSCs in 2D and in both systems in 3D when cultured in OM. A significant down-regulation of Sox9 expression was found after monolayer or pellet
culture in BM, OM and CM. Sox9 expression was significantly up-regulated after 7 and 28 days of culture in CM on FDM-scaffolds. On ES-scaffolds
an initial significant increase for Sox9 expression was found after 7 days of culture in CM while the gene seemed to be down-regulated at day 14 and 28
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Sox9 was down-regulated in CM at all time-points and in BM for all
time-points after 7 days of culture. Collagen-1 expression was
initially significantly up-regulated in BM and OM. After 14 days
the expression stabilized at the same level as the 2D control after
1 day of culture. In both FDM-scaffolds and ES-scaffolds, a more
profound up-regulation of chondrogenic or osteogenic marker
expression after culture in CM and OM, respectively, was found
for pre-selected hMSCs than for the more heterogeneous popu-
lations of hMSCs from donors 2 and 3.
3.2. Differentiation potential of hMSCs in 3D scaffolds by
protein expression analysis
To investigate whether or not up-regulation of osteogenic or
chondrogenic genes resulted in a functional change in the
behaviour of the cells behavior, protein expression analysis
was carried out (Fig. 4). ALP activity was determined as an
indicator of osteogenic behavior and glycosaminoglycan (GAGs)
secretion was determined as an indicator of chondrogenesis.
Both ALP activity and GAG secretion were first normalized to
the number of cells per sample, which was determined by DNA
quantification. The results of DNA quantification can be found
in the ESI,† Fig. S6, from which it can be seen that there are just
slight changes in DNA quantities over time and between different
culture media. No direct correlation between the cell number and
the ALP activity per cell or GAG production per cell was observed
(Fig. 4 and ESI,† Table S3).
ALP activity increased significantly over time for hMSCs in
both scaffold types when cultured in OM, whereas in BM and
CM it was minimally produced. A significant increase in GAG
production was observed for hMSCs cultured in CM after
28 days on FDM-scaffolds, and after 3, 7, 21 and 28 days on
ES-scaffolds. Furthermore, a significant increase in GAG pro-
duction was found after 28 days in OM on FDM-scaffolds and
Fig. 3 Relative mRNA expression of collagen-1 and collagen-2 for pre-selected hMSCs cultured in 2D as a monolayer (BM and OM) or a pellet (CM) on
TCPS and in 3D on two different scaffold systems. Collagen type-1 and collagen type-2 expression followed similar trends over time in 2D and in 3D per
scaffolding system. The collagen type-1 and collagen type-2 expression fluctuated over-time and remained down-regulated after 28 days of culture in
BM in both scaffold types (n = 5, # p o 0.05, @ p o 0.01, * p o 0.001, Dunnett’s posttest with BM 2D day 1 as control).
Fig. 4 Protein expression analysis showed an increase in ALP activity over
time for hMSCs in both scaffold types when cultured in OM, whereas in BM
and CM the ALP activity was maintained at a basal level. A significant
increase in GAG production was observed for hMSCs cultured in CM after
28 days on FDM-scaffolds and after 3, 7, 21 and 28 days on ES-scaffolds
(n = 5, # p o 0.05, @ p o 0.01, * p o 0.001, Dunnett’s posttest with BM 2D
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after 21 days in OM and BM on ES-scaffolds. To compare the
expression levels of pre-selected hMSCs on 3D scaffolds to a
more heterogeneous population of hMSCs, protein expression
levels were determined for cells cultured for 3, 7, 14, 21 and 28
days on FDM-scaffolds (donor 2) and on ES-scaffolds (donor 3)
(ESI,† Fig. S7). For both assays the results of DNA quantification
are given in the ESI,† Fig. S8. For both donors a positive
correlation between the ALP activity and the application of OM
was found. The up-regulation of ALP activity on ES-scaffolds was
observed at an earlier time-point than for FDM-scaffolds, which
was also observed with the pre-selected donor (Fig. 4). GAG
expression was significantly up-regulated in the presence of CM
on FDM-scaffolds after 7 days of culture and on ES-scaffolds after
7, 14, 21 and 28 days of culture. In BM and OM, GAG production
was also up-regulated after 14, 21 and 28 days, and after 21 and
28 days, respectively.
3.3. SEM analysis of ECM production after soluble factor
induced differentiation
The distribution and morphology of the cells and ECM
throughout the 3D scaffolds were assessed by SEM (Fig. 5). In
FDM-scaffolds, CM resulted often in lower cell numbers and
less ECM production than BM and OM. However, the ECM that
was secreted showed collagen-like ECM fibers with a tendency
to align into bundles, whereas in BM and OM this orientation
appeared more random. Furthermore, in CM, vacuole-like struc-
tures were observed in the ECM (Fig. 5B indicated with an
arrow). On ES-scaffolds, no profound differences were observed
at the micro-scale and all culture media resulted in a dense
cellular layer on top of the sheets with cells penetrated in
between the scaffold fibers (Fig. 5G–I).
3.4. Loss of the differentiated state of hMSCs in FDM- and
ES-scaffolds upon the removal of soluble factors
The stability of differentiated phenotype was assessed for pre-
selected hMSCs as well as for more heterogeneous populations
of hMSCs from donor 2, 3 and 4 on FDM- and ES-scaffolds.
Soluble factors were removed by replacing the culture media
with BM after 14 days of inducing differentiation into the
chondrogenic (dex and TGF-b3) and osteogenic (dex) lineages
on FDM- and ES-scaffolds, a procedure that will further be
referred to as the de-differentiation phase. The culture period
was prolonged for another 3 or 14 days to investigate if changes
in gene expression levels and protein production were observed
with respect to the specimens that were further cultured in
differentiation media. Fig. 6A shows the gene expression levels
for BM, CM and OM for day 14 and day 28, as already presented in
Fig. 2 and 3, to enable visual comparison to the results of the de-
differentiation phase introduced here. As can be observed in Fig. 6,
the ALP expression significantly increased in OM after 14, 17 and
28 days in both scaffold types compared to the levels for BM after
14 days of culture. After 3 days of potential de-differentiation, the
ALP expression levels in OB were still significantly up-regulated
compared to day 14 in BM; however, a small decrease was
observed compared to OM at the same time-point. After 14 days
of potential de-differentiation, there was no significant difference
Fig. 5 SEM analyses after 28 days of culture on FDM scaffolds (A–F) and ES-scaffolds (G–I). Under all three culture conditions BM (A, D and G), CM
(B, E and H) and OM (C, F and I) collagen-like ECM matrix deposition was found. The scaffolds showed a dense outer layer of cells under all conditions. In
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in ALP expression levels between samples in BM and OB, whereas
in OM the expression remained up-regulated.
In FDM-scaffolds, a significant increase in Sox9 expression
was found only after 17 days of culture in CM, whereas in
ES-scaffolds a significant down-regulation was found after
28 days in CM. In CB, no differences were observed after
3 days or 14 days of de-differentiation compared to BM after
14 days of culture. Similarly to the results presented in Fig. 3,
the expression of collagen-1 and collagen-2 expression showed
the same trends per scaffold type. In the two scaffold types, the
expression of collagen-1 and collagen-2 was slightly or under
some conditions even significantly up-regulated after 17 days of
culture, whereas down-regulation was found under all condi-
tions after 28 days of culture.
The stability of gene expression levels after differentiation
was also assessed for donor 2 on FDM-scaffolds, for donor 3 on
ES-scaffolds, and for donor 4 on FDM-scaffolds (ESI,† Fig. S9,
S10 and S11, respectively). In the FDM-scaffolds, it was
observed that Sox9, collagen-1 and collagen-2 generally showed
similar trends per donor, which was also observed for donor 1
on FDM-scaffolds. There seemed to be no correlation between
the gene expression of ALP, ACAN and ALCAM per donor.
Fig. 6 (A) RT-QPCR results after 14 days of soluble-factor-induced differentiation followed by 3 or 14 days of de-differentiation. ALP gene expression on
FDM-scaffolds significantly increased in OM after 14, 17 and 28 days in both scaffold types compared to the levels for BM after 14 days of culture. After
14 days of de-differentiation there was no significant difference between BM and OB, whereas OM remained up-regulated. In FDM-scaffolds a significant
increase in Sox9 expression was found only after 17 days of culture in CM, whereas in ES-scaffolds a significant down-regulation was found after 28 days
in CM. In CB no differences were observed after 3 days or 14 days of de-differentiation compared to BM after 14 days of culture. The expression collagen
type-1 and collagen type-2 was slightly or under some conditions even significantly up-regulated after 17 days of culture, whereas a down-regulation
was found under all conditions after 28 days of culture. (B) ALP activity showed an up-regulation in OM over time as observed before, yet the ALP activity
in OB did not change in FDM-scaffolds compared to OM at day 14. In ES-scaffolds the ALP activity was decreased compared to OM at day 14. GAG
expression showed a significant up-regulation in CM after 17 and 28 days of culture in both scaffold types. In CB this up-regulation was found to be even
higher after 17 days on ES-scaffolds whereas a decrease in GAG production was found in FDM-scaffolds at the same time-point ((A) n = 5, (B) n = 4, # p o
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Donors 2 and 4 did not show a consistent positive correlation
between ALP gene expression and the presence of OM. Also for
the markers of chondrogenesis, Sox9, ACAN and collagen-2,
no positive correlation was found between the gene expression
levels and the presence of CM. For donor 3 hMSCs on
ES-scaffolds, ALP was significantly down-regulated under
most of the conditions compared to BM day 14. Only after
14 days of de-differentiation after osteogenic differentiation,
the gene expression levels were restored to comparable levels
as for hMSCs in BM after 14 days of culture. Sox9 and ACAN
showed a consistent but not significant down-regulation in
CM compared to BM at day 14 on ES-scaffolds. Also this down-
regulation was lost during the de-differentiation phase.
To investigate the functional response of hMSCs upon
de-differentiation, protein expression levels were analyzed
(Fig. 6B). BM, CM and OM after 14 and 28 days of differentia-
tion culture are based on the same results as presented in
Fig. 4. ALP activity in OM showed an up-regulation over time
as observed before. Yet, the ALP activity in OB did not change
in FDM-scaffolds compared to OM at day 14. In ES-scaffolds,
the ALP activity was decreased compared to OM at day 14 and
showed no significant difference with BM at day 14. GAG
expression showed a significant up-regulation in CM after
17 and 28 days of culture in both scaffold types. In CB, this
up-regulation showed to be even higher after 17 days on
ES-scaffolds whereas a decrease in GAG production was found
in FDM-scaffolds at the same time-point. After 14 days of
de-differentiation GAG production was significantly increased
in CB compared to BM at day 14. However, the GAG amount
was lower than that for CM after 28 days of culture. ESI,†
Fig. S12 shows the protein production levels for donors 2
and 4 on FDM-scaffolds and for donor 3 on ES-scaffolds. It
can be observed that only donor 2 and 3 hMSCs showed a
significant increase in ALP activity when cultured in OM, and
this activity was lost upon the removal of soluble factors. With
respect to GAG production, only donor 4 showed a response in
CM, whereas for the other 2 donors no profound changes
in GAG production were found. In just a few cases where a
change in the protein production levels was observed for
heterogeneous populations of hMSCs after differentiation,
de-differentiation resulted in a decrease of these protein production
levels. For pre-selected hMSCs, this effect of the de-differentiation
phase on protein production levels was found to be much
stronger.
4. Discussion
Several studies have been reported on the differentiation
potential of hMSCs when cultured on 3D scaffolds with or
without the addition of soluble factors.40,41 However, as far as
we know, there is limited knowledge available on the stability of
the differentiated phenotype after in vitro culture of hMSC on
such 3D scaffolds. In many tissue engineering applications,
scaffolds cultured in vitro with hMSCs ultimately have to be
implanted in a defect site. Therefore, it is of high importance to
assess whether the results achieved in vitro have the potential to
be maintained upon implantation.42
Here, differentiation towards the osteogenic and chondro-
genic lineages was induced by the introduction of well-known
soluble factors in the culture media. Basic medium (BM) served
as a negative control on differentiation, assuming that similar
to that in 2D also in 3D no differentiation will be induced by
the media components in BM. As expected, the two different
scaffold types did not seem to change the cellular phenotype of
pre-selected hMSCs towards the osteogenic or chondrogenic
lineage without the presence of differentiation inducing media.
In BM, there were no significant differences in mRNA expres-
sion levels in both scaffold systems and in 2D culture for ALP,
collagen-1 and collagen-2 after 3, 7, 21 or 28 days of culture
compared to the control group in BM in 2D after 1 day of
culture. Also ALP activity and GAG production did not show
consistent changes over time for hMSCs in BM in any of the
scaffold systems for both the colony-picked hMSCs and the
three more heterogeneous hMSCs populations. Overall, there is
a strong indication that none of the two scaffold-types consis-
tently and significantly induced osteogenic or chondrogenic
differentiation in both pre-selected hMSCs and in the more
heterogeneous populations of hMSCs in the absence of differ-
entiation inducing soluble factors. Similar results were recently
reported by Manferdini et al. who showed soluble-factor depen-
dency of the differentiation of hMSCs on biomimetic gradient
composite scaffolds.43 From their results on differentiation, it
could be concluded that the type of media used dominated over
the potential influence of the properties of scaffolds. In our
study, the over-time fluctuations in gene expression levels in
BM found in nearly all experiments in 3D were in the same
order as the fluctuations found in 2D culture and therefore the
properties of scaffolds are not expected to contribute to this
inconsistency in gene expression.
To assess whether the two scaffolds in this study support
soluble-factor induced hMSC differentiation, differentiation
towards osteogenic and chondrogenic lineages was assessed.
As an indication of osteogenic differentiation capacity, both
scaffold systems showed an up-regulation of ALP expression
and ALP activity over time when the pre-selected hMSCs
were cultured in OM. The corresponding fold increases were
comparable to the levels observed in 2D over time. This
soluble-factor-induced change in cellular phenotype was partly
lost when OM was replaced by BM after 14 days of differentia-
tion, which again suggests that the scaffold by itself does not
induce or promote hMSC differentiation towards the osteogenic
lineage.
The induced chondrogenic response on CM in pellet-culture
(presented as 2D) was not as profound as the osteogenic
response on OM. Sox9, an early marker for chondrogenesis,
did not consistently increase over time. In contrast, in 2D and
pellet-culture it showed a direct decrease in BM and OM, and
CM, respectively. In 3D, a positive correlation between CM
and Sox9 gene expression was only found in FDM-scaffolds. A
down-regulation of Sox9 in combination with an up-regulation
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3D and could be associated with differentiation towards the
osteogenic lineage.44
A negative response in Sox9, collagen-2 and ACAN was found
for hMSCs from donor 3 cultured in CM on ES-scaffolds. The
differentiation potential towards the chondrogenic lineage for
this heterogeneous population of hMSCs cultured in pellets
could not be assessed since the quantities of isolated RNA were
too low to run further analysis. For this donor, it could be
concluded that these hMSCs lack differentiation potential
towards the chondrogenic lineage under traditional chondro-
genesis inducing culture conditions. ES-scaffolds might still be
favorable as a 3D support for chondrogenic differentiation, in
case the hMSC population of interest shows a high potential to
differentiate into the chondrogenic lineage in pellet-culture.
Low RNA quantities were not observed for the pellet-cultures
of the other donors and hence could be an effect of donor
variation.37,45 In summary, gene expression levels for pre-
selected hMSCs showed a more profound response to osteo-
genic factors than the hMSCs from the other donors, probably
due to the heterogeneity of those cell populations. Further-
more, pre-selected hMSCs showed a positive correlation
between ALP gene expression levels and ALP activity, as well
as between Sox-9 gene expression and GAG production. For
the more heterogeneous populations of hMSCs, a positive and
consistent response on differentiation inducing factors was
only found in protein expression. The discrepancy between
the fluctuating gene expression levels and the more consistent
protein expression levels can be related to a faster response of
RNA transcription processes on extra and intracellular signals
than the response of more down-stream post-transcriptional
modifications and protein translation processes. Protein
expression cumulates in the cells and in the ECM, whereas
RNA transcription can be regulated at a faster rate. This could
be the case when a pathway for the production of a specific
protein is activated; this pathway could be inhibited by a
negative feedback when a sufficient amount of protein has
been synthesized. The corresponding gene expression could
show down-regulation because RNA transcription is inhibited,
whereas the produced protein remains active and detectable.
To the best of our knowledge, the influence of the solid 3D
scaffold culture environment on these specific differentiation
related pathways in hMSCs has not yet been explored thor-
oughly. More studies on the molecular level should aid in
unravelling these differentiation pathways in complex envir-
onments, taking into account the heterogeneity of the cell
populations and the observed donor variation for multiple
time-points.46 Even though heterogeneous populations of
hMSCs showed fluctuating gene expression levels, the use of
these heterogeneous populations from older patients is more
clinically relevant since in future therapies pre-selection of
hMSCs might be too costly and time-consuming. For example,
in the context of skeletal regeneration one could think of
combining 3D scaffolds with heterogeneous hMSCs being
retrieved from the subchondral bone marrow after performing
microfracture,47 the latter being the current standard as first-
line therapy for cartilage repair.48
With respect to de-differentiation, generally, it was observed
that when hMSCs showed a positive response on CM or OM
towards the chondrogenic or osteogenic lineage, respectively,
the differentiated phenotype was lost within 3 or 14 days after
the removal of soluble factors. Both the response on differen-
tiation inducing factors and the loss of the differentiated
phenotype upon de-differentiation were found to be stronger
in pre-selected hMSCs than in hMSCs from donors 2, 3 and 4.
From these results, it can be concluded that the soluble-factor-
induced differentiated phenotype of pre-selected hMSCs showed
to be dependent on the presence of such soluble factors. The
phenotypic stability of more heterogeneous populations of
hMSCs also showed to be limited, since the increased protein
expression levels were lost upon the removal of soluble factors
under most of the conditions similarly to the results for pre-
selected hMSCs.
With the results presented herein, we would like to empha-
size that for future in vitro tissue engineering it is important to
bear in mind that successful soluble factor induced differentia-
tion of any population of hMSCs does not necessarily result in a
stable commitment of the hMSCs to the targeted lineage when
such soluble factors are not available anymore. Therefore, the
development of differentiation inductive scaffolds that will
retain their intrinsic instructive cues over long time-periods
could be vital for future tissue engineering applications.
5. Conclusions
In this study, soluble-factor-induced differentiation of hMSCs
was assessed for its stability on two distinct polymeric scaffold
types and compared to their differentiation capacity in 2D.
Firstly, we showed that soluble-factor-induced differentiation
was neither completely inhibited nor dominantly promoted by
the scaffold properties, which makes them potentially suitable
non-inductive supports for several tissue engineering applica-
tions. Secondly, after the removal of soluble factors, the
possibly differentiated phenotype of the hMSCs was found
to be lost and the mRNA expression levels of the majority of
the assessed genes returned to comparable levels as for
hMSCs that were cultured in non-inductive media during
the full time-period of the study. From these results, we
conclude that although some scaffold types might be opted
as promising candidates to support hMSC differentiation and
tissue growth, these scaffolds do not always guarantee a stable
differentiated phenotype when soluble factors are not avail-
able anymore. In future tissue engineering approaches, when
combining scaffolds with hMSCs to be differentiated into a
certain lineage in vitro, the stability of the differentiation
phenotype should be assessed to better predict the function-
ality of constructs upon implantation.
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